{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T20:40:14Z","timestamp":1775508014304,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,8]],"date-time":"2015-11-08T00:00:00Z","timestamp":1446940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13643-015-0142-z","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T10:21:44Z","timestamp":1446718904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Nebulised dornase alfa versus placebo or hypertonic saline in adult critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis"],"prefix":"10.1186","volume":"4","author":[{"given":"Casper","family":"Claudius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Perner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten Hylander","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,8]]},"reference":[{"issue":"6","key":"142_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/MCP.0b013e328358d51f","volume":"18","author":"JS Wagener","year":"2012","unstructured":"Wagener JS, Kupfer O. Dornase alfa (Pulmozyme). Curr Opin Pulm Med. 2012;18(6):609\u201314.","journal-title":"Curr Opin Pulm Med"},{"key":"142_CR2","first-page":"CD001127","volume":"3","author":"AP Jones","year":"2010","unstructured":"Jones AP, Wallis C. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev. 2010;3:CD001127.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"142_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa1012740","volume":"365","author":"NM Rahman","year":"2011","unstructured":"Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365(6):518\u201326.","journal-title":"N Engl J Med"},{"issue":"3","key":"142_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1442-200X.2010.03245.x","volume":"53","author":"U Dilmen","year":"2011","unstructured":"Dilmen U, Karagol BS, Oguz SS. Nebulized hypertonic saline and recombinant human DNase in the treatment of pulmonary atelectasis in newborns. Pediatrics Int. 2011;53(3):328\u201331.","journal-title":"Pediatrics Int"},{"issue":"8","key":"142_CR5","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.rmed.2012.04.002","volume":"106","author":"RA Silverman","year":"2012","unstructured":"Silverman RA, Foley F, Dalipi R, Kline M, Lesser M. The use of rhDNAse in severely ill, non-intubated adult asthmatics refractory to bronchodilators: a pilot study. Respir Med. 2012;106(8):1096\u2013102.","journal-title":"Respir Med"},{"issue":"2","key":"142_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.anl.2010.09.001","volume":"38","author":"JG Mainz","year":"2011","unstructured":"Mainz JG, Schiller I, Ritschel C, Mentzel HJ, Riethmuller J, Koitschev A, et al. Sinonasal inhalation of dornase alfa in CF: a double-blind placebo-controlled cross-over pilot trial. Auris Nasus Larynx. 2011;38(2):220\u20137.","journal-title":"Auris Nasus Larynx"},{"issue":"8","key":"142_CR7","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1177\/1060028014535199","volume":"48","author":"KA Thornby","year":"2014","unstructured":"Thornby KA, Johnson A, Axtell S. Dornase alfa for non-cystic fibrosis pediatric pulmonary atelectasis. Ann Pharmacother. 2014;48(8):1040\u20139.","journal-title":"Ann Pharmacother"},{"key":"142_CR8","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions, version 5.1.0. 2012. http:\/\/handbook.cochrane.org\/ ."},{"key":"142_CR9","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"142_CR10","doi-asserted-by":"publisher","first-page":"f457","DOI":"10.1136\/bmj.f457","volume":"346","author":"O Ciani","year":"2013","unstructured":"Ciani O, Buyse M, Garside R, Pavey T, Stein K, Sterne JA, et al. Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study. BMJ. 2013;346:f457.","journal-title":"BMJ"},{"issue":"2","key":"142_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/EJA.0000000000000118","volume":"32","author":"I Jammer","year":"2015","unstructured":"Jammer I, Wickboldt N, Sander M, Smith A, Schultz MJ, Pelosi P, et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol. 2015;32(2):88\u2013105.","journal-title":"Eur J Anaesthesiol"},{"issue":"4","key":"142_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395\u2013400.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"142_CR13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"key":"142_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2288-9-86","volume":"9","author":"J Wetterslev","year":"2009","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol. 2009;9:86.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"142_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","volume":"61","author":"J Wetterslev","year":"2008","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61(1):64\u201375.","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"142_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/sim.4088","volume":"30","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Whitehead A, Simmonds M. Sequential methods for random-effects meta-analysis. Stat Med. 2011;30(9):903\u201321.","journal-title":"Stat Med"},{"key":"142_CR17","unstructured":"TSA. Trial sequential analysis (TSA). The Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet. Copenhagen, Denmark. Software and manual available at www.ctu.dk\/tsa ; 2011."},{"issue":"9","key":"142_CR18","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/sim.1761","volume":"23","author":"MJ Sweeting","year":"2004","unstructured":"Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23(9):1351\u201375.","journal-title":"Stat Med"},{"issue":"2","key":"142_CR19","doi-asserted-by":"publisher","first-page":"218 e1","DOI":"10.1016\/j.jcrc.2012.09.015","volume":"28","author":"JN Zitter","year":"2013","unstructured":"Zitter JN, Maldjian P, Brimacombe M, Fennelly KP. Inhaled dornase alfa (Pulmozyme) as a noninvasive treatment of atelectasis in mechanically ventilated patients. J Crit Care. 2013;28(2):218 e1\u20137.","journal-title":"J Crit Care"},{"issue":"6","key":"142_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/jamp.2011.0954","volume":"25","author":"HA Youness","year":"2012","unstructured":"Youness HA, Mathews K, Elya MK, Kinasewitz GT, Keddissi JI. Dornase alpha compared to hypertonic saline for lung atelectasis in critically ill patients. J Aerosol Med Pulm Drug Delivery. 2012;25(6):342\u20138.","journal-title":"J Aerosol Med Pulm Drug Delivery"},{"issue":"1","key":"142_CR21","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1186\/cc11919","volume":"17","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care. 2013;17(1):R2.","journal-title":"Crit Care"},{"issue":"6","key":"142_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","volume":"157","author":"J Savovic","year":"2012","unstructured":"Savovic J, Jones HE, Altman DG, Harris RJ, Juni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med. 2012;157(6):429\u201338.","journal-title":"Ann Intern Med"},{"issue":"2","key":"142_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1204242","volume":"367","author":"A Perner","year":"2012","unstructured":"Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, et al. Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis. N Engl J Med. 2012;367(2):124\u201334.","journal-title":"N Engl J Med"},{"issue":"16","key":"142_CR24","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMoa1212722","volume":"368","author":"D Heyland","year":"2013","unstructured":"Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489\u201397.","journal-title":"N Engl J Med"},{"issue":"9","key":"142_CR25","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D Backer De","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779\u201389.","journal-title":"N Engl J Med"},{"issue":"9","key":"142_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1215554","volume":"368","author":"ND Ferguson","year":"2013","unstructured":"Ferguson ND, Cook DJ, Guyatt GH, Mehta S, Hand L, Austin P, et al. High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med. 2013;368(9):795\u2013805.","journal-title":"N Engl J Med"},{"issue":"7565","key":"142_CR27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/bmj.38902.605347.7C","volume":"333","author":"KM Ho","year":"2006","unstructured":"Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006;333(7565):420.","journal-title":"BMJ"},{"issue":"1","key":"142_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1017\/S0266462303000072","volume":"19","author":"R Grieve","year":"2003","unstructured":"Grieve R, Thompson S, Normand C, Suri R, Bush A, Wallis C. A cost-effectiveness analysis of rhDNase in children with cystic fibrosis. Int J Technol Assess Health Care. 2003;19(1):71\u20139.","journal-title":"Int J Technol Assess Health Care"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-015-0142-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-015-0142-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-015-0142-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,2]],"date-time":"2016-10-02T02:55:23Z","timestamp":1475376923000},"score":1,"resource":{"primary":{"URL":"http:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-015-0142-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["142"],"URL":"https:\/\/doi.org\/10.1186\/s13643-015-0142-z","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,8]]},"article-number":"153"}}